Sinovac Biotech Ltd.
Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities
Published in Vaccine Weekly, December 9th, 2009
Sinovac Biotech Ltd. (NASDAQ:SVA), a leading developer and provider of vaccines, announced that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Mr. Weidong Yin, Chairman, President and CEO of Sinovac, remarked, "Sinovac Dalian brings to Sinovac a highly efficient platform to expand our manufacturing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-12-09)
More Articles from Vaccine Weekly
- Bioengineering
Reports outline bioengineering study findings from Technical University of Dresden - H1N1 Virus
Research from Tor Vergata University in the area of h1n1 virus published - Human Papillomavirus
Studies from C. Velicer and co-researchers in the area of human papillomavirus published - Human Papillomavirus
Study findings from E.F. Dunne et al provide new insights into human papillomavirus - Immunization
Recent findings in immunization described by researchers from University of Applied Sciences - Immunization
Report summarizes immunization study findings from J. Chow and co-researchers - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
